Annexin Pharmaceuticals AB (publ) (STO: ANNX)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.483
+0.001 (0.21%)
Dec 3, 2024, 1:34 PM CET

ANNX Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-52.45-44.05-40.73-52.14-44.24-28.36
Upgrade
Depreciation & Amortization
0.190.190.190.190.190.19
Upgrade
Other Operating Activities
-0-5.194.284.03
Upgrade
Change in Accounts Payable
-0.751-0.180.610.49-0.71
Upgrade
Change in Other Net Operating Assets
0.44-0.54-0.451.130.08-0.88
Upgrade
Operating Cash Flow
-52.56-43.4-41.17-45.02-39.2-25.73
Upgrade
Investment in Securities
-0.1-0.26--0.1-
Upgrade
Investing Cash Flow
-0.1-0.26--0.1-
Upgrade
Long-Term Debt Issued
---204-
Upgrade
Long-Term Debt Repaid
-----4.23-0.23
Upgrade
Net Debt Issued (Repaid)
-10--20-0.23-0.23
Upgrade
Issuance of Common Stock
80.6736.523.1166.6661.01-
Upgrade
Other Financing Activities
-3.77-2.9-0.05-10.29-7.62-
Upgrade
Financing Cash Flow
66.933.6123.0676.3753.16-0.23
Upgrade
Miscellaneous Cash Flow Adjustments
--0----
Upgrade
Net Cash Flow
14.34-9.7-18.3731.3513.87-25.95
Upgrade
Free Cash Flow
-52.56-43.4-41.17-45.02-39.2-25.73
Upgrade
Free Cash Flow Per Share
-0.14-0.26-0.28-0.55-0.64-1.45
Upgrade
Cash Interest Paid
----0.50.03
Upgrade
Levered Free Cash Flow
-33.04-26.87-26.05-28.92-23.16-15.43
Upgrade
Unlevered Free Cash Flow
-33.04-26.87-26.05-27.76-22.85-15.41
Upgrade
Change in Net Working Capital
0.31-0.460.83-5.07-4.85-2.47
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.